Abstract
The objective of this guidance document is to provide advice on the use of an additional dose of a COVID-19 vaccine following receipt of a standard 1- or 2-dose primary series in moderately to severely immunocompromised individuals in Canada.
- Recommendation
- Americas
- Canada
- immunocompromised
- COVID-19
